Tech Company Financing Transactions

Vaccinogen Funding Round

Private investors participated in a $2.5 million venture round for Vaccinogen. The round was announced on 3/12/2010.

Transaction Overview

Company Name
Announced On
3/12/2010
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
949 Fell St. 2nd Floor
Baltimore, MD 21231
USA
Email Address
Overview
Vaccinogen is a biotechnology company with more than three decades of research into combating cancer by using the body's own immune system. It is the producer of OncoVAX, the only immunotherapy for Stage II colon cancer.
Profile
Vaccinogen LinkedIn Company Profile
Social Media
Vaccinogen Company Twitter Account
Company News
Vaccinogen News
Facebook
Vaccinogen on Facebook
YouTube
Vaccinogen on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Andrew Tussing
  Andrew Tussing LinkedIn Profile  Andrew Tussing Twitter Account  Andrew Tussing News  Andrew Tussing on Facebook
Chief Operating Officer
Peter Morsing
  Peter Morsing LinkedIn Profile  Peter Morsing Twitter Account  Peter Morsing News  Peter Morsing on Facebook
Founder
Michael Hanna
  Michael Hanna LinkedIn Profile  Michael Hanna Twitter Account  Michael Hanna News  Michael Hanna on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/12/2010: bluebird bio venture capital transaction
Next: 3/14/2010: OfferIQ venture capital transaction

 

Share this article

 


Where The Data Comes From

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary